Kea Insight / Analyst Relations
Your Product Roadmap Is Not a Market Forecast
Your roadmap is a statement of intent. The market is under no obligation to follow it.
Technology companies are very good at turning internal conviction into external certainty. A customer asks for something. A competitor launches something. Sales says a capability is blocking deals. Product sees a pattern. The roadmap changes.
Sometimes that is exactly the right response. Sometimes it is the beginning of a very expensive misunderstanding.
The problem is not that product teams lack data. Most have too much of it. The problem is knowing which signals describe the market, which describe a handful of accounts and which simply repeat what the company already believes.
This is where Analyst Relations can contribute far more than briefing preparation. Analysts sit across categories, vendors and buyer conversations. Used properly, they can help a company test whether an internal product assumption survives contact with the wider market before that assumption becomes twelve months of engineering work.
1. A roadmap is not evidence
A roadmap tells people what the company intends to build, improve or retire. It helps align engineering, product, commercial teams and customers around direction. That makes it useful. It does not make it a forecast of what the market will need when the work is finished.
The distinction sounds obvious until you look at how roadmap decisions are discussed. A request appears repeatedly in Salesforce. A competitor announces a capability. A strategic customer asks for an integration. An analyst publishes research showing growth in a category. Each can quickly become evidence that the company “has to” build something.
But each signal answers a different question.
A customer request tells you what that customer asked for. A lost deal tells you something happened in that buying process. A competitor announcement tells you what the competitor wants the market to know. A research forecast describes a defined market under a stated methodology. None automatically proves that your target buyers will adopt your proposed capability at the price, timing and operating model you have in mind.
The first discipline is therefore simple: separate the decision from the evidence supporting it. If the roadmap item is “build capability X”, ask what must be true for that investment to create value. Who needs it? What problem changes? Why now? What are buyers doing instead? What would make them choose not to adopt it even if the technology works?
If those questions have not been answered, the roadmap item is still a hypothesis. It may be a very good one. But calling it committed does not make the market evidence stronger.
2. Your loudest signal may not be your most important one
Product organisations are surrounded by signals, but the signals arrive with very different levels of bias.
Existing customers know your product and have already accepted its architecture, commercial model and implementation effort. Strategic accounts have disproportionate access to your executives. Sales remembers the losses that hurt. Customer success hears from the people who care enough to complain. Product teams naturally spend more time with users willing to engage.
All of that information is useful. None of it is automatically representative.
Ten feature requests from one customer are still one customer. Five salespeople repeating the same objection may all have learned it from the same battlecard. Three prospects asking for an integration may represent an emerging requirement—or three accounts with the same incumbent system.
The mistake is not listening to these signals. The mistake is removing their context.
For every important roadmap claim, keep the source attached. Which customer segment? Which geography? Which buyer role? Existing customer or prospect? Won, lost or no decision? Was the request volunteered, prompted or inferred? Is it based on observed behaviour or stated intention?
That context often changes the decision. A capability that matters deeply to ten large regulated customers may deserve investment even if it is not a broad market trend. Equally, a capability requested by many enthusiastic users may have little commercial impact if the economic buyer, security team or procurement function blocks adoption.
3. Inside-out product planning has a market cost
Companies naturally become experts in their own product. That expertise creates a blind spot: internal language begins to feel like market language.
Teams talk about the category they believe they are creating, the differentiation they believe buyers value and the roadmap they believe will move them ahead. Over time, those assumptions reinforce one another. Sales decks, product plans, analyst briefings and investor narratives all begin using the same words.
The danger is that repetition looks like validation.
Analysts can expose that gap because they do not begin with your organisational structure or roadmap. They begin with the market they cover: the problems buyers describe, the categories they recognise, the vendors they compare and the criteria that repeatedly matter in research and advisory conversations.
If your product team believes a planned capability will redefine the category but analysts still hear buyers prioritising implementation simplicity, integration, governance or cost predictability, that does not automatically make the roadmap wrong. It tells you the burden of proof is higher than the internal conversation suggests.
That is valuable information before the build starts. It is much more expensive information after launch.
4. Analysts can challenge the assumption before the investment
Many vendors involve analysts far too late in product decisions.
The roadmap is agreed. Engineering has started. Marketing is naming the launch. Then AR is asked to arrange a briefing so analysts can hear what is coming.
At that point, the conversation is mainly communication. The company has already made the important decisions.
A stronger use of analyst access happens earlier. Instead of asking an analyst to react to a finished proposition, bring the market assumption into an inquiry or advisory conversation while there is still room to change it.
The objective is not to ask the analyst to design the product. Nor is it to obtain a quote saying the roadmap is correct. It is to use someone with a wider market view to challenge the assumptions the company may be overconfident about.
An analyst may have seen the same problem expressed differently by buyers. They may know that a capability attracting vendor attention is becoming table stakes rather than differentiation. They may see that adoption depends less on the headline feature than on migration, governance, deployment model or commercial structure.
One analyst opinion is still one input. Treat it as such. The value comes from the question it helps you investigate, not from attaching the analyst’s name to the conclusion.
5. Ask questions that can actually change the roadmap
A weak analyst question produces a weak product signal.
“Do you think this is a good feature?” invites opinion. “Are buyers asking for AI?” is so broad that almost any answer can be interpreted as support. “What do you think of our roadmap?” turns a strategic discussion into a tour of internal priorities.
Ask questions that expose the conditions under which the roadmap assumption holds.
- Which buyer problem is becoming more important in this market, and for whom?
- What are buyers doing today instead of adopting this type of capability?
- Which requirements are becoming expected rather than differentiating?
- What typically prevents adoption even when a buyer likes the technology?
- Which stakeholder tends to stop or delay the purchase?
- Where do vendors overestimate the importance of this capability?
- What evidence would make the proposition more credible to an enterprise buyer?
- What would have to change in the market for your view to change?
These questions are uncomfortable by design. They create the possibility that the answer changes scope, timing, target segment or even the decision to build.
If no answer is allowed to change the roadmap, the conversation is not research. It is confirmation.
6. Do not compare your future product with a competitor’s present
Roadmaps often contain an invisible timing error.
A company looks at what competitors offer today, identifies a gap and builds towards an advantage twelve or eighteen months away. The business case then quietly assumes the competitor will remain where it is.
That is rarely a safe assumption.
Analysts can help because competitive movement is part of the market context they track. They may see where multiple vendors are investing, which capabilities are converging and where differentiation is disappearing.
This does not mean treating every competitor announcement as truth. Roadmap statements, previews and launch claims need the same scrutiny whether they come from your company or someone else’s.
The important comparison is not your future product against today’s market. It is your intended position against the plausible market that will exist when you arrive.
Sometimes that means a planned differentiator is likely to become a basic requirement. That may make the capability more important to build, but less valuable as a premium message. Sometimes it means a competitor’s headline feature matters less than their distribution, installed base or deployment model. The engineering response and the market response may therefore be very different.
7. The buyer is larger than the user
Product demand is often collected from the people closest to the product. Enterprise adoption is decided by a much larger group.
The user may love the capability. Security may reject the data flow. The sponsor may support the project. Procurement may dislike the commercial model. The architecture team may insist on a deployment pattern the product does not support. Operations may conclude that implementation creates more work than the benefit removes.
This is one reason analyst insight matters in B2B technology. Analysts often hear not just what users want, but what buying organisations require in order to proceed.
That wider view can expose the difference between product interest and market readiness.
A roadmap item can therefore be technically feasible, desirable to users and still commercially weak because the organisation around the user cannot adopt it. If the product decision ignores those conditions, engineering ends up solving the visible problem while the buying friction remains untouched.
Ask not only “will someone use this?” Ask “what must be true for an organisation to buy, deploy and continue using it?”
8. Research forecasts are context, not your revenue plan
Market forecasts are useful because they provide a structured view of a category: its definition, expected development, geographic scope and spending assumptions. They can help leadership understand whether a market is expanding, consolidating or changing shape.
They are not a shortcut to your own commercial forecast.
If an analyst firm expects a market to grow, that does not tell you how much of that growth is accessible to your company. Your position depends on the customers you can reach, the problem you solve, the competition you encounter, the sales motion, the implementation burden, pricing, retention and the evidence buyers require from you specifically.
This matters because market numbers can create false confidence around roadmap investments. A large category forecast makes almost any adjacent capability look strategically sensible.
Use research to understand the environment. Then build the company-level case separately.
What percentage of the relevant market can you realistically address? Which accounts are actually eligible? How many can your commercial team reach? What has to be true for them to switch? What does deployment cost you? Where will competitors be by then?
The gap between “the market is growing” and “we can win profitable business here” is where most of the real work sits.
9. Turn insight into an explicit product decision
Analyst insight has little value if it ends in a meeting note.
When external evidence challenges a roadmap assumption, give the finding somewhere to go. Product leadership should decide whether the response is to continue, narrow, investigate, defer, partner or stop.
That decision should record three things: what changed, what evidence supports the change and what would cause the team to revisit it.
For example:
Continue: the market need remains well supported and the new insight strengthens the current direction.
Narrow: evidence supports the capability for one segment or use case, but not the broad proposition originally planned.
Investigate: the signal is material but not yet strong enough to justify the next level of investment.
Defer: the opportunity may be real, but timing, dependencies or buyer readiness are not there yet.
Partner: the market requires an adjacent capability that another provider can deliver more credibly than building it internally.
Stop: the assumptions supporting the investment no longer justify further commitment.
The point is not to make product planning indecisive. It is to make changing course legitimate when the evidence changes.
10. A practical example: when “AI demand” is not one thing
Imagine a B2B software company hearing the same message from several directions: competitors are launching AI assistants, customers are asking about AI and analysts are publishing heavily on the subject.
The easy conclusion is that the roadmap needs an AI assistant.
The harder question is what buyers are actually trying to improve.
Suppose customer conversations show that users spend hours preparing evidence for a recurring operational review. They like the idea of asking questions conversationally, but the real pain is assembling reliable information from several systems.
An analyst conversation adds another dimension. Enterprise buyers in this area are less concerned with whether the interface is conversational than with data permissions, traceability, governance and whether the answer can be defended internally.
Now the roadmap discussion changes.
The original proposition was “we need an AI assistant because the market is moving to AI”. The revised proposition becomes “we need to help this buyer complete a high-friction evidence task, and AI may be one component if we can meet the trust and data requirements”.
That could lead to a smaller product, a different architecture, a different buyer, a different commercial model—or the same broad product with a much stronger reason to exist.
The analyst did not design the solution. The analyst helped the company ask a better market question before the internal assumption became the product.
11. Build market learning into the roadmap cadence
None of this works if market insight is treated as a one-off exercise before annual planning.
Markets move. Competitors reposition. Buyer requirements change. Capabilities that once differentiated become expected. New regulation, architecture choices or procurement constraints can alter adoption without changing the underlying customer problem.
Product teams already have roadmap reviews. Analyst Relations should feed relevant external evidence into that rhythm rather than creating a parallel reporting process.
That does not mean dragging every analyst comment into product planning. The job is to filter.
What has materially changed? Which analyst view is relevant to the segment and decision? Is the signal supported by research, repeated buyer conversations or other evidence? Does it challenge an assumption currently carrying meaningful investment?
A useful cadence might be quarterly for major roadmap assumptions, with faster escalation when evidence materially affects a committed product, market claim or customer promise.
AR then becomes more than the function that communicates the roadmap externally. It becomes one of the mechanisms that helps the company keep the roadmap connected to the market it is trying to serve.
12. Where Kea adds value
Kea works with technology companies at the point where market understanding needs to become a business decision.
For product teams, that means identifying which analysts can contribute useful perspective, framing the questions around the actual uncertainty and separating a meaningful market signal from an interesting opinion.
We do not replace customer discovery, product leadership or engineering judgement. Nor should an analyst decide what your company builds.
Our role is to make sure the business is not making important product decisions with less external market understanding than it could reasonably have.
Before the next major roadmap commitment, take one item and ask three questions. What do we believe about the market? What evidence supports that belief beyond our own organisation? And what would we change if that belief turned out to be wrong?
If the third question has no answer, the roadmap may already have become too certain.
Your roadmap is a statement of intent. Keep it connected to the market before the market makes the correction for you.
Read alongside Your analyst subscription is not a strategy. It is a stepping stone. and The analyst disagrees with you. That does not make them wrong.
Put this into practice
Test the assumptions behind your roadmap
Bring product, sales and leadership together to examine market evidence, challenge assumptions and agree what to validate before committing further investment.
Explore AR WorkshopsNot sure where to start? Take the eight-question AR Readiness Check.